Merck & Company, Inc. vs Orthofix Medical Inc. — Stock Comparison

MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
vs
OFIX
Orthofix Medical Inc.
$11.91
▲ 1.28%
Q·Score Winner
Merck & Company, Inc.
MRK6.7/10vs 6.3/10

Q·Score Breakdown

6.7
Neutral
Overall
6.3
Neutral
6.2
Quality
2.5
7
Health
8.9
6.2
Growth
6.1
7.2
Valuation
8.7
7.1
Sentiment
5.9
MRK

Forward P/E of 11.5× is low relative to sector peers.

OFIX

Clean balance sheet with low leverage (0.5× debt-to-equity).

currently unprofitable (-11% margin).

Analyst Consensus

BUY
Target $129.74 (+15.7%)
27 analysts
BUY
Target $17.25 (+44.8%)
4 analysts

Fundamentals

MRK
OFIX
31.5×
Trailing P/E
11.5×
Forward P/E
13.9×
13.6%
Profit Margin
-11.2%
76.6%
Gross Margin
68.8%
ROE
-19.3%
4.9%
Revenue Growth
2.0%
Earnings Growth
0.28
Beta
0.82
Price / Book
$277.0B
Market Cap
$481M
$73 – $125
52-Week Range
$10 – $17

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →